# mrna

#TradFi交易分享挑战
#TradFiTradeShareChallenge
#mrna
$MRNA ‌MRNA began to pull strong focus again inside the biotech group in the recent period. Good data flow for the mRNA-based flu shot and a new FDA review step made volume rise in the share. The firm’s cancer care work and bug-control projects also back the mid-term outlook.
At this stage price finds balance near the 48 zone. The 46.5 zone works like the main short-run guard area. As long as it holds above this part, the 51 and 54 zones can turn into goals again. If a high-volume break comes above 54, a firmer drive can form in the mid-term.

🚀📈💰🔥🪙📊😎⚡💹🎯🤑
"A trader without a strategy is like Wi-Fi in an elevator: there’s a signal, but the money still doesn’t get through!" 😅 Today at Gate Square, it’s a really hot TradFi day, and tokens USIDX, MU, MRNA, CVX, and AMZN are already experiencing increased volatility. According to Gate Markets, the highest activity is now shown by AMZN — the daily trading volume has increased by almost 18%, and open interest in the TradFi sector continues to grow. MU demonstrates strong momentum after positive news from the AI chip sector, and MRNA has again become a magnet for speculative trad